Exenatide Affects Circulating Cardiovascular Risk Biomarkers Independently of Changes in Body Composition

OBJECTIVE: To study the effect of exenatide on body composition and circulating cardiovascular risk biomarkers. RESEARCH DESIGN AND METHODS: Metformin-treated patients with type 2 diabetes (N = 69) were randomized to exenatide or insulin glargine and treated for 1 year. Body composition was evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales: Bunck, Mathijs C., Diamant, Michaela, Eliasson, Bjorn, Cornér, Anja, Shaginian, Rimma M., Heine, Robert J., Taskinen, Marja-Riitta, Yki-Järvinen, Hannele, Smith, Ulf
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2010
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909051/
https://www.ncbi.nlm.nih.gov/pubmed/20424219
http://dx.doi.org/10.2337/dc09-2361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909051/
https://www.ncbi.nlm.nih.gov/pubmed/20424219
http://dx.doi.org/10.2337/dc09-2361

Ejemplares similares